Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor

SIMPLE SUMMARY: Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death of women worldwide. Several cut-points for estrogen receptor (ER) and progesterone receptor (PgR) have been proposed as predictive effects of hormone therapy; while the cut-off values were incon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tai-Han, Gao, Hong-Wei, Liao, Guo-Shiou, Yu, Jyh-Cherng, Dai, Ming-Shen, Ho, Jar-Yi, Yu, Cheng-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926358/
https://www.ncbi.nlm.nih.gov/pubmed/33670083
http://dx.doi.org/10.3390/cancers13040905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926358/
https://www.ncbi.nlm.nih.gov/pubmed/33670083
http://dx.doi.org/10.3390/cancers13040905

Ejemplares similares